Showing 2,461 - 2,480 results of 3,189 for search '"vaccination"', query time: 0.08s Refine Results
  1. 2461

    Laboratory Diagnosis of Mumps in a Partially Immunized Population: The Nova Scotia Experience by TF Hatchette, R Davidson, S Clay, J Pettipas, J LeBlanc, S Sarwal, M Smieja, KR Forward

    Published 2009-01-01
    “…BACKGROUND: In 2007, Atlantic Canada experienced a large outbreak of mumps predominately in university students who had received a single dose of measles, mumps and rubella vaccine. The present study describes the performance characteristics of reverse transcriptase polymerase chain reaction (RT-PCR) on buccal and urine specimens and immunoglobulin M (IgM) serology in this partially immune population.…”
    Get full text
    Article
  2. 2462

    Serum Sickness following Tetanus Toxoid Injection by Saja alhawal, Manar Aldarwish, Zainab Almoosa

    Published 2021-01-01
    “…In this case, we describe a case of 6-year-old girl who developed a rash and arthralgia after being vaccinated with tetanus toxoid injection after a cut wound.…”
    Get full text
    Article
  3. 2463

    AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells by Galindo-Hernández Octavio, Vique-Sánchez José Luis

    Published 2022-09-01
    “…The COVID-19 pandemic is ongoing and the benefit from vaccines is still insufficient since COVID-19 continues to be dia g-nosed in vaccinated individuals. …”
    Get full text
    Article
  4. 2464

    Circulating Dynamics of SARS-CoV-2 Variants between April 2021 and February 2022 in Turkey by Murat Sayan, Ayse Arikan, Murat Isbilen

    Published 2022-01-01
    “…The diagnosis of new variants and monitoring their potential effects on diagnosis, therapeutics, and vaccines by genomic sequencing is essential to manage global public crises. …”
    Get full text
    Article
  5. 2465

    Induction of Tolerance via the Sublingual Route: Mechanisms and Applications by Philippe Moingeon, Laurent Mascarell

    Published 2012-01-01
    “…The clinical efficacy of sublingual immunotherapy (SLIT) with natural allergen extracts has been established in IgE-dependent respiratory allergies to grass or tree pollens, as well as house dust mites. Sublingual vaccines have an excellent safety record, documented with approximately 2 billion doses administered, as of today, in humans. …”
    Get full text
    Article
  6. 2466

    Evolutionary Pattern of Asian HIV-1 Subtype B from 1990 to 2007: In Silico Analysis Based on Envelop Protein by Sobia Kanwal, Tariq Mahmood

    Published 2012-01-01
    “…HIV-1 envelop gene is a major target for vaccine development. Envelop protein and its V3 loop is shown to be important determinant of HIV-1 pathogenecity. …”
    Get full text
    Article
  7. 2467

    A replication-incompetent adenoviral vector encoding for HSV-2 gD2 is immunogenic and protective against HSV-2 intravaginal challenge in mice. by Elisa Rossetti, Marija Vujadinovic, Ella van Huizen, Jeroen Tolboom, Hanneke Schuitemaker, Feng Yao, Roland Zahn, Eirikur Saeland

    Published 2024-01-01
    “…We have designed an adenoviral vector type 35 (Ad35)-based vaccine encoding the HSV-2 major surface antigen gD2 (Ad35.HSV.gD2). …”
    Get full text
    Article
  8. 2468

    IMMUNOBIOLOGICAL PROPERTIES OF LUMPY SKIN DISEASE VIRUS STRAIN LSD CATTLE/DAGESTAN/2015 by S. V. Kononova, O. P. Byadovskaya, A. V. Kononov, I. N. Shumilova, E. E. Artyukhova

    Published 2018-04-01
    “…It is type specific and with its immunobiological characteristics meets the standards and requirements set before virus strains used for vaccine and diagnostic production.…”
    Get full text
    Article
  9. 2469

    Bovine Genital Campylobacteriosis by Max B. Irsik, Jan K. Shearer

    Published 2007-04-01
    “…Shearer, DVM, MS, describes this venereal disease of cattle formerly known as vibriosis, clinical findings and epidemiology, how to determine if there is a campylobacter problem in a herd, and the use of vaccines. Published by the UF Department of Veterinary Medicine -- Large Animal Clinical Sciences, March 2007. …”
    Get full text
    Article
  10. 2470

    Bovine Genital Campylobacteriosis by Max B. Irsik, Jan K. Shearer

    Published 2007-04-01
    “…Shearer, DVM, MS, describes this venereal disease of cattle formerly known as vibriosis, clinical findings and epidemiology, how to determine if there is a campylobacter problem in a herd, and the use of vaccines. Published by the UF Department of Veterinary Medicine -- Large Animal Clinical Sciences, March 2007. …”
    Get full text
    Article
  11. 2471
  12. 2472

    The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model by Jagoda Mierzejewska, Katarzyna Węgierek-Ciura, Joanna Rossowska, Agnieszka Szczygieł, Natalia Anger-Góra, Bożena Szermer-Olearnik, Magdalena Geneja, Elżbieta Pajtasz-Piasecka

    Published 2022-01-01
    “…Application of the developed DC-based vaccines may exert a favorable impact on stimulation of an antitumor immune response, especially if these DC vaccines are administered repeatedly.…”
    Get full text
    Article
  13. 2473

    CELLULAR IMMUNITY AND CYTOKINE PROFILE IN PRE-FARROW AND LACTATING SOWS by A. G. Shakhov, S. V. Shabunin, L. Yu. Sashnina, M. I. Adodina, M. Yu. Zhejnes, K. V. Tarakanova, K. O. Kopytina

    Published 2019-10-01
    “…The cytokine profile of the sows was specified by the recovered numbers of interleukin-1β, tumor necrosis factor-α and γ-interferon, decreased level of interleukin-2 and interleukin-4 that regulate cellular and humoral immunity, respectively as well as their subsequent increase (in particular, interleukin-2) following animal immunization against parvoviral infection and erysipelas on day 7 post farrowing (Parvoruvax vaccine, Merial, France) and against classical swine fever on day 14 post farrowing (culture dry virus-vaccine LK-VNIVIPFIT). …”
    Get full text
    Article
  14. 2474

    Outer Membrane Proteome Analysis of Indian Strain of Pasteurella multocida Serotype B:2 by MALDI-TOF/MS Analysis by A. Prasannavadhana, Santosh Kumar, Prasad Thomas, Laxmi Narayan Sarangi, Santosh Kumar Gupta, Adyasha Priyadarshini, Viswas Konasagara Nagaleekar, Vijendra Pal Singh

    Published 2014-01-01
    “…Further functional in vivo study of the proteins identified are required to explore the utility of these proteins in developing diagnostics and vaccine against HS.…”
    Get full text
    Article
  15. 2475

    Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclon... by Matteo Castelli, Francesca Cappelletti, Roberta Antonia Diotti, Giuseppe Sautto, Elena Criscuolo, Matteo Dal Peraro, Nicola Clementi

    Published 2013-01-01
    “…Here, we review several strategies based on experimental techniques alone or addressed by in silico analysis that are frequently used to predict immunogens to be included in novel epitope-based vaccine approaches. We will list the main strategies aiming to design a new vaccine preparation conferring the protection of a neutralizing mAb combined with an effective cell-mediated response.…”
    Get full text
    Article
  16. 2476

    Immunostimulatory Effects of Guanine-Quadruplex Topologies as Scaffolds for CpG Oligodeoxynucleotides by Soumitra Pathak, Nguyen Bui Thao Le, Taiji Oyama, Yusuke Odahara, Atsuya Momotake, Kazunori Ikebukuro, Chiho Kataoka-Hamai, Chiaki Yoshikawa, Kohsaku Kawakami, Yoshihisa Kaizuka, Tomohiko Yamazaki

    Published 2025-01-01
    “…Synthetic cytosine-phosphate-guanine oligodeoxynucleotides (CpG ODNs) are promising candidates for vaccine adjuvants, because they activate immune responses through the Toll-like receptor 9 (TLR9) pathway. …”
    Get full text
    Article
  17. 2477

    Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992–2008) by Matthias Imöhl, Ralf René Reinert, Mark van der Linden

    Published 2010-01-01
    “…The temporal variations in serotype distribution have to be kept in mind when interpreting vaccine coverages reported in epidemiological studies.…”
    Get full text
    Article
  18. 2478
  19. 2479
  20. 2480

    Convalescent plasma therapy in severe coronavirus disease-2019: A narrative review by Rasmi Ranjan Sahoo, Kasturi Hazarika, Prashant Bafna, Manesh Manoj, Anupam Wakhlu

    Published 2020-01-01
    “…Until, a specific antiviral therapy or an effective vaccine is made available, the consideration for use of convalescent blood products, especially plasma, is warranted. …”
    Get full text
    Article